C: Use with warning if Advantages outweigh dangers. Animal reports exhibit hazard and human research not readily available or neither animal nor human research performed.Stay clear of coadministration of sensitive CYP2C9 substrates with ivosidenib or change with alternate therapies. If coadministration is unavoidable, check sufferers for loss of th